Navigation Links
Estradiol EIA Test

ProductsEstradiol EIA Test
Company Diagnostic Systems Laboratories, Inc.
Item Estradiol EIA Test
Features 
Description Estradiol (E2) is the most potent, naturally secreted estrogen and is the major estrogen produced by the ovary [1]. In the ovary, estradiol is produced from testosterone [1,2], and from estrone, a less potent estrogen derived from androstenedione. Estrone and estradiol are interconverted in many body tissues. In men, small amounts of estradiol are produced in the testes and from peripheral conversion of androgens. The biological actions of estradiol include stimulation of linear bone growth, acceleration of epiphyseal closure, stimulation of mammary development, and maturation of the vaginal mucosa and uterine endometrium. Estradiol may also contribute to the development of the female (gynoid) body habitus, and may have metabolic and behavioral effects [1].

In adult premenopausal women, ovarian estradiol production is stimulated by the interactions of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) throughout the menstrual cycle. The increasing estradiol levels during the follicular phase of the menstrual cycle appear to enhance gonadotropin stimulation, leading to a midcycle gonadotropin surge and subsequent ovulation [1]. Increased estradiol (and progesterone) levels during the luteal phase inhibit gonadotropin secretion. In adult women, estradiol levels are measured in the evaluation of fertility and menstrual irregularities, and to monitor ovarian follicular function during induction of ovulation (e.g. as part of an in vitro fertilization procedure) [3].

  1. Ca ez MS, et al. Infertil Reproduct Med Clin North Amer 3:59-78, 1992.
  2. Miller WL. Endocrin Rev 9:295-318, 1988.
  3. Hughes EG, et al. J Endocrinol Metab 70:358-364, 1990.
Info Diagnostic Systems Laboratories, Inc.
Customer Service: (800) 231-7970
Web site: http://www.dslabs.com

Related medicine products :

1. Estradiol EIA Reproductive Markers 020-DR-2693 Hormones
2. 3rd Generation Estradiol RIA Test
3. 3rd Generation Estradiol EIA
4. Estradiol RIA Test
5. Estradiol (E2) Enzyme Immunoassay
6. Estradiol, Ultra-Sensitive RIA Test
7. Estradiol EIA kit
8. Coat-a-Count Estradiol RIA
9. BioCheck Estradiol (E2) Enzyme Immunoassay
10. Double Antibody Estradiol RIA
11. Estradiol ELISA
Full plate covers seal all 24 MicroAmp tubes...
An alternative sealing method for samples that are stored in 96-well plates after PCR. The mat is fully autoclavable and can be reused up to 50 times....
Inquire...
Pkg qty: box of 2 bags pack of 25 (Pack = Zippered Bag)...
Medicine Products:
(Date:5/5/2015)... 2015 AxoGen, Inc. (NASDAQ: AXGN), ... $1.6 billion peripheral nerve repair market, reported record revenue ... 31, 2015 compared to $3.14 million in the year-ago ... our proprietary portfolio of nerve repair products - ... Protector – and our solid sales execution delivered another ...
(Date:5/5/2015)... The 2015 Crystal Ball, hosted by the Hepatitis ... outreach and patient advocacy programs. The gala evening included dancing, ... hundreds of supporters. , The 2015 gala was dedicated to ... virus (HBV) by Dr. Baruch S. Blumberg, who passed away ... for his discovery of the virus in 1976. He and ...
(Date:5/5/2015)... 05, 2015 Baptist Medical Center Jacksonville’s ... Cancer (CoC) of the American College of Surgeons. , ... meet more than 30 Commission on Cancer quality care ... process, and maintain levels of excellence in the delivery ... choose to seek care locally at a CoC-accredited cancer ...
(Date:5/5/2015)... " QuickPick Travel ” was featured on NewsWatch as ... small, medium, and large businesses making an impact in their ... expert, conducted the business review and shared with viewers how ... weeks of vacation for free. , Vacations are a sought-after ... world. And when people are preparing for vacations, they’re used ...
(Date:5/5/2015)... NY (PRWEB) May 05, 2015 ProTexting, ... that enables businesses to deploy Mobile Engagement Campaigns and ... Contact . ProTexting clients can now leverage the power ... by collecting and syncing subscribers’ e-mail addresses into the ... “We have recognized that the growing trend of multi-channel ...
Breaking Medicine News(10 mins):Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 2Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 3Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 4Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 2Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 2Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 4Health News:A Platform to Plan the Perfect Vacation was Featured on NewsWatch Television 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 3
... The Delhi High Court Wednesday held that the misuse of ... seriously, stressing that their services be availed of only ... and Justice S.N. Agrawal said: "No ambulance of any of ... used by the medical staff for their private use." ...
... E. McGreevy appears to be knocking on a different door. ... for the right reasons. He has been welcomed into ... James E. McGreevy, who was brought up as a Roman ... at St. Bartholomew's Church in New York. He is presently ...
... says she was upset when her pictures appeared in magazine ... all that blew up, I felt terrible. It appeared that ... am thin because that's what I am, and I was ... Nothing else," people.com quotes her as saying to a magazine. ...
... official of the United Arab Emirates (UAE) said the government ... part of the country's prevention programme of genetic disorders. ... the mother or child's health. But the choice to have ... we decide has to be within the religious and social ...
... that the malfunction of a gene causes schizophrenia and ... of the journal Neuron. ,The researchers said their ... developing treatments for schizophrenia and depression, which have been ... ,In their experiments, the researchers sought to ...
... who have migraine headaches are more than twice as likely ... than soldiers who do not have migraines, according to ... who were given a health screening questionnaire within 90 days ... A total of 2,167 of the soldiers, or 60 percent, ...
Cached Medicine News:Health News:Malfunction of Gene Causes Schizophrenia, Depression 2Health News:Migraines may Be a Symptom of Other Problems for Iraq Soldiers 2
(Date:5/5/2015)... 5, 2015  Adeptus Health Inc. (NYSE: ADPT ... pricing of the previously announced offering of 2,100,000 shares ... shares are to be sold by the Company, and ... of Sterling Partners (the "Selling Stockholder"), at a price ... the Company and the Selling Stockholder have granted the ...
(Date:5/5/2015)... May 5, 2015   InspireMD, Inc. (NYSE MKT: ... systems, announced today that it will release its full financial ... Monday, May 11 th before the open, followed by ... financial results and business outlook. Participants should call ... 542-4135 (International) and request the InspireMD call. A live webcast ...
(Date:5/5/2015)... , May 5, 2015 Ardelyx, ... company focused on cardio-renal, gastrointestinal, and metabolic diseases, ... trial evaluating tenapanor in Stage 3 chronic kidney ... albuminuria did not meet the primary endpoint of ... compared to patients receiving placebo. ...
Breaking Medicine Technology:Adeptus Health Inc. Announces Pricing of Common Stock Offering 2Adeptus Health Inc. Announces Pricing of Common Stock Offering 3Adeptus Health Inc. Announces Pricing of Common Stock Offering 4InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 3Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 2Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 3Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 4Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 5Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 6